Nicolas C. Roche
Expertise in
16
conditions

Nicolas C. Roche

Paris, FR 
Expertise in
16
conditions
Paris, FR 

Overview

Nicolas Roche practices practicing medicine in Paris, France.

Mr. Roche is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Spasticity, Mastectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 525 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Paris, France
Other Locations
Villejuif, France
Versailles, 78000, France
Garches, 92380, France
Aix-en-provence, 13454, France
Marseille, France
Saclay, France
261, Boulevard Du Mercantour, Nice, France
Les Hotelleries, France
Saint-quentin-le-verger, France
Paris Est Créteil University, 51 Avenue Du Maréchal De Lattre De Tassigny, Creteil, 94000, France
Rue Jean Baptiste Perret, Saint-cyr-sur-le-rhone, 69450, France
94160, France
La Tronche, France
Chambery, 73376, France
Boulogne-billancourt, 92100, France
Descartes, France
Rene, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial
Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial
Enrollment Status: Terminated
Publish Date: June 12, 2026
Intervention Type: Drug
Study Drug: 5 days of Systemic Corticotherapy (Prednisone)
Study Phase: Phase 3
Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Zephyr Etude Post-Inscription (French Registry)
Zephyr Etude Post-Inscription (French Registry)
Enrollment Status: Completed
Publish Date: February 18, 2026
Intervention Type: Device
Etude de l'Effet de Stimulations transcrâniennes en Courant Continu (tDCS) Sur Les Performances en dénomination Chez le Sujet Aphasique à Moins d'un an de Son Accident Vasculaire cérébral : Comparaison de 5 Configurations de Stimulation
Etude de l'Effet de Stimulations transcrâniennes en Courant Continu (tDCS) Sur Les Performances en dénomination Chez le Sujet Aphasique à Moins d'un an de Son Accident Vasculaire cérébral : Comparaison de 5 Configurations de Stimulation
Enrollment Status: Terminated
Publish Date: September 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
Double Blind Randomized Controlled Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength of These Muscles During Locomotion in Chronic Hemiparetic Patients
Double Blind Randomized Controlled Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength of These Muscles During Locomotion in Chronic Hemiparetic Patients
Enrollment Status: Completed
Publish Date: May 30, 2019
Intervention Type: Drug
Study Phase: Phase 3
Phase 1 Evaluation of the Influence of Settings of Word Prediction Software (Phase 1)and the Efficiency of Rehabilitation Programm (Phase 2)to Text Input Speed for People With Spinal Cord Injury
Phase 1 Evaluation of the Influence of Settings of Word Prediction Software (Phase 1)and the Efficiency of Rehabilitation Programm (Phase 2)to Text Input Speed for People With Spinal Cord Injury
Enrollment Status: Completed
Publish Date: September 06, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

525 Total Publications

Visible mould and blood inflammatory phenotypes of asthma in adults: the CONSTANCES cohort.
Visible mould and blood inflammatory phenotypes of asthma in adults: the CONSTANCES cohort.
Journal: Thorax
Published: August 07, 2026

Frequently Asked Questions about Nicolas C. Roche

Is Nicolas C. Roche a top-rated expert for Chronic Obstructive Pulmonary Disease (COPD)?

MediFind is an objective health platform that identifies experts based on real-world data. Nicolas C. Roche is classified as an Elite expert for Chronic Obstructive Pulmonary Disease (COPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nicolas C. Roche participate in research or clinical trials?

Yes. Nicolas C. Roche has published 525 articles and abstracts on conditions like Chronic Obstructive Pulmonary Disease (COPD). You can view a list of Nicolas C. Roche's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roche's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 45 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile